BAX - BAXTER INTERNATIONAL INC

QQQ $ 431.01 $ 6.55 (1.54 %)

DIA $ 382.27 $ 1.39 (0.36 %)

SPY $ 508.26 $ 4.77 (0.95 %)

TLT $ 88.26 $ 0.46 (0.52 %)

GLD $ 216.60 $ 0.70 (0.32 %)

Previous Close

$ 40.13

Open

$ 40.26

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 39.97 - $ 40.37

52 Week Range

$ 30.55 - $ 49.12

Volume

2,013,221

Average Volume

Market Cap

20.31B

Beta (5Y Monthly)

$ 0.63

PE Ratio (TTM)

$ 7.65

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.03)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	02-08-2024	12-31-2023	10-K
2	11-02-2023	09-30-2023	10-Q
3	07-27-2023	06-30-2023	10-Q
4	04-27-2023	03-31-2023	10-Q
5	02-09-2023	12-31-2022	10-K
6	10-27-2022	09-30-2022	10-Q
7	07-28-2022	06-30-2022	10-Q
8	04-28-2022	03-31-2022	10-Q
9	02-23-2022	12-31-2021	10-K
10	10-28-2021	09-30-2021	10-Q
11	07-29-2021	06-30-2021	10-Q
12	04-29-2021	03-31-2021	10-Q
13	02-11-2021	12-31-2020	10-K
14	10-29-2020	09-30-2020	10-Q
15	07-30-2020	06-30-2020	10-Q
16	04-30-2020	03-31-2020	10-Q
17	03-17-2020	09-30-2019	10-Q
18	03-17-2020	12-31-2019	10-K
19	07-30-2019	06-30-2019	10-Q
20	05-08-2019	03-31-2019	10-Q
21	02-21-2019	12-31-2018	10-K
22	11-05-2018	09-30-2018	10-Q
23	08-06-2018	06-30-2018	10-Q
24	05-09-2018	03-31-2018	10-Q
25	02-23-2018	12-31-2017	10-K
26	11-02-2017	09-30-2017	10-Q
27	08-07-2017	06-30-2017	10-Q
28	05-04-2017	03-31-2017	10-Q
29	02-23-2017	12-31-2016	10-K
30	11-07-2016	09-30-2016	10-Q
31	08-04-2016	06-30-2016	10-Q
32	05-06-2016	03-31-2016	10-Q
33	02-26-2016	12-31-2015	10-K
34	11-09-2015	09-30-2015	10-Q
35	08-07-2015	06-30-2015	10-Q
36	05-06-2015	03-31-2015	10-Q
37	02-26-2015	12-31-2014	10-K
38	10-29-2014	09-30-2014	10-Q
39	07-30-2014	06-30-2014	10-Q
40	04-30-2014	03-31-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Baxter Expands Pharmaceuticals Portfolio W...
04/11/2024 12:32:06

Five new launches reinforce Baxter's focus on differentiated products and enhance the company's Pharmaceuticals portfol...

Assessing Baxter Intl: Insights From 4 Fin...
04/03/2024 16:00:53

Citigroup Maintains Neutral on Baxter Intl...
04/03/2024 15:34:06

Citigroup analyst Joanne Wuensch maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $41 to $44.

medical-devices-giant-baxter-secures-fda-approval-for-new-infusion-pump-system

Medical Devices Giant Baxter Secures FDA A...
04/01/2024 16:38:56

FDA clears Baxter's Novum IQ LVP & SYR infusion pumps with Dose IQ Safety Software, streamlining training & reducin...

Baxter Announces US FDA Clearance of Novum...
04/01/2024 11:16:07

Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food an...

10-health-care-stocks-with-whale-alerts-in-todays-session

10 Health Care Stocks With Whale Alerts In...
03/20/2024 17:35:24

why-are-dialysis-provider-stocks-trading-higher-on-tuesday

Why Are Dialysis Provider Stocks Trading H...
03/05/2024 20:21:24

Novo Nordisk's FLOW trial reveals a 24% reduction in kidney disease progression, cardiovascular events, and death with sema...

B of A Securities Maintains Neutral on Bax...
03/05/2024 14:39:06

B of A Securities analyst Travis Steed maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $42 ...

Spectral Medical Announces Amendment And E...
02/21/2024 21:02:33

Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT), a late-stage theranostic company advancing thera...

Barclays Maintains Overweight Rating for B...
02/12/2024 17:00:30

JP Morgan Maintains Neutral on Baxter Intl...
02/09/2024 19:58:57

JP Morgan analyst Robbie Marcus maintains Baxter Intl (NYSE:BAX) with a Neutral and raises the price target from $38 to $44.

baxter-says-2023-performance-reflects-strategic-initiatives-with-new-operating-model-without-biopharma-solutions-unit

Baxter Says 2023 Performance Reflects Stra...
02/08/2024 17:51:52

Baxter's Q4 2023 results: $3.89 billion revenue, surpassing consensus, 4% Y/Y growth. Strong sales in Medical Products, The...

Baxter Forecasts FY24 Adjusted EPS Of $2.8...
02/08/2024 12:20:20

Baxter Forecasts Q1 FY24 Adjusted EPS Of $...
02/08/2024 12:19:10

Baxter Intl Q4 Adjusted EPS $0.88 Beats $0...
02/08/2024 12:16:48

Baxter Intl (NYSE:BAX) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.86 by 2.3...

Earnings Scheduled For February 8, 2024
02/08/2024 09:43:03

Companies Reporting Before The Bell • Ares Management (NYSE:ARES) is expected to report quarterly earnings at $1.09 per share ...

Baxter Has Completed The First Phase Of It...
12/14/2023 13:02:37

dont-miss-these-3-high-yielding-dividend-stocks-in-health-care-sector-from-wall-streets-most-accurate-analysts

Don't Miss These 3 High-Yielding Dividend ...
12/12/2023 13:48:03

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

Morgan Stanley Maintains Equal-Weight Rati...
12/04/2023 17:00:25

Morgan Stanley Maintains Equal-Weight on B...
12/04/2023 12:35:20

Morgan Stanley analyst Patrick Wood maintains Baxter Intl (NYSE:BAX) with a Equal-Weight and lowers the price target from $4...